🇺🇸 FDA
Patent

US 8709476

Compositions of quaternary ammonium compounds containing bioavailability enhancers

granted A61KA61K31/14A61K47/12

Quick answer

US patent 8709476 (Compositions of quaternary ammonium compounds containing bioavailability enhancers) held by Supernus Pharmaceuticals, Inc. expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/14, A61K47/12, A61K47/18, A61K9/2013